Camlin Fine Sciences Limited has informed the Exchange regarding allotment of 4106181 securities pursuant to Preferential Issue at its meeting held on November 30, 2025
CAMLINFINE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Camlin Fine Sciences Limited has allotted 41,06,181 equity securities to specific investors under a Preferential Issue. The allotment was approved at a board meeting held on November 30, 2025. Preferential issues are private placements made directly to selected investors at a price determined by the board, rather than through a public offering like a QIP. The announcement does not disclose the issue price, names of allottees, or the purpose of raising funds. This represents a fresh infusion of capital from identified investors into the company.
The preferential allotment will increase the share capital of Camlin Fine Sciences, leading to dilution for existing shareholders. Depending on the issue price and use of funds, it could strengthen the company's balance sheet but may put short-term pressure on the stock due to dilution. Investors should watch for further disclosures on pricing and end use of proceeds.